← Open Payments lookup

FRANCIS MAE MAGDADARO: Open Payments

NPI 1376200337 · ANAHEIM, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,233 in 151 payments from 20 companies in 2025. Trend: 2023 $3,545 · 2024 $2,714 · 2025 $3,233

Food & beverage: $3,233
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.21$677
Otsuka America Pharmaceutical, Inc.19$443
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)21$399
ABBVIE INC.22$358
E.R. Squibb & Sons, L.L.C.14$240
Lundbeck LLC13$223
Teva Pharmaceuticals USA, Inc.8$172
Alkermes, Inc.8$168
Janssen Pharmaceuticals, Inc8$138
Noven Therapeutics, LLC4$84

Products named: INGREZZA, REXULTI, CAPLYTA, VRAYLAR, COBENFY, ARISTADA, INVEGA SUSTENNA, ABILIFY MAINTENA.

Industry payments across CA — which companies pay providers there.